A senolysis-based theragnostic prodrug strategy towards chronic renal failure
Yihe Song(East China University of Science and Technology), Jian Li(Sir Run Run Shaw Hospital), Tianyue Sun(Aesthetic Surgery Center), Yuan Guo(Ministry of Education of the People's Republic of China), Xinming Li(East China University of Science and Technology), Wenwen Liu(East China University of Technology), Xin Chen(Jinan University), Donglei Shi(Hainan University), Xiaokang Li(East China University of Science and Technology), Sicong Qiao(East China University of Science and Technology)
Cited by 41
Related Papers
Mitochondrial dysfunction: roles in skeletal muscle atrophy
|Journal of Translational Medicine|2023|275
Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin
|Biomaterials|2013|118
Evaluation of HOCl-generating anticancer agents by an ultrasensitive dual-mode fluorescent probe
|Chemical Science|2019|118